January 9, 2022
LOS ANGELES -- Calibre Scientific is pleased to announce the acquisition of Medline Scientific, a distributor of laboratory consumables and equipment with headquarters in Oxfordshire, United Kingdom. Medline Scientific further enhances Calibre Scientific’s growing distribution presence in the United Kingdom. Medline Scientific is a premier distributor of laboratory products to a broad range of domestic [...]
OriGene Technologies Updates Logo for Rebranding Its Expansion from Genomics to Proteomics
January 7, 2022
ROCKVILLE, Md. -- OriGene updates its logo, signifying its evolvement from genomic to proteomic market. The logo modification includes an addition of antibody/antigen image to the previous logo, highlighting the expansion of OriGene's product portfolio from genomic (plasmids/RNAi/PCR) to proteomic (protein/antibody/assays). In the past 25 years, OriGene has dedicated to creation of the world's largest source of [...]
FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve …
January 7, 2022
MADISON, Wis., and SAN DIEGO -- FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) technologies, and PhenoVista Biosciences (PhenoVista), a top provider of custom imaging-based phenotypic assay services, today announce a strategic alliance to improve the drug discovery process, by using iPSCs in screening. This alliance [...]
Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe
January 7, 2022
MENLO PARK, Calif. -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical Center (Radboudumc) in Nijmegen, the Netherlands will increase their SMRT sequencing capacity with the addition of two new PacBio Sequel IIe Systems. Radboudumc has been using PacBio long-read technology for the last three years [...]
908 Devices Announces GSK Purchases Fifth REBEL Cell Culture Media Analyzer
January 7, 2022
BOSTON -- 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, today announced that GlaxoSmithKline (NYSE: GSK) has purchased an additional REBEL™ cell culture media analyzer. GSK will now have a total of five REBEL analyzers being used by its biologics and vaccine process development teams. “We are pleased that GSK [...]
Halma appoints President for the Asia Pacific region
January 7, 2022
Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Aldous Wong as President of the Asia Pacific region. Reporting to Group Chief Executive Andrew Williams, Aldous will lead Halma’s growth in China and the wider region. This will include seeking new M&A opportunities and growing Halma’s existing companies in [...]
January 7, 2022
Expanding range of applications for growing base of QIAcuity digital PCR instruments Two new collaborations: Atila BioSystems expands menu to non-invasive prenatal testing (NIPT), while Actome partnership designed to enable for the first time protein analysis using digital PCR technology HILDEN, Germany & GERMANTOWN, Md. -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today [...]
Boekel Scientific Pleased to Display the New AABB Corporate Partner Logo
January 7, 2022
PHILADELPHIA -- Boekel Scientific, a globally recognized designer and manufacturer of laboratory equipment and medical devices, including market-leading blood banking products, is proud to be among the companies displaying the new Corporate Partner logo of AABB (The Association for the Advancement of Blood and Biotherapies). AABB is a connected community dedicated to advancing transfusion medicine and biotherapies. Its [...]
Azenta Life Sciences Names Matthew McManus Chief Operating Officer
January 6, 2022
CHELMSFORD, Mass. -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th. In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO. "We are excited to have Matt join the Company as our [...]
SINGULAR GENOMICS APPOINTS GENOMICS RESEARCH PIONEER ELAINE R. MARDIS, PH.D., TO BOARD OF DIRECTORS
January 6, 2022
LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the addition of Elaine R. Mardis, Ph.D., to the Company’s Board of Directors. Dr. Mardis is a pioneering researcher internationally recognized in cancer genomics with a focus on [...]

